Patients with glioblastoma have very few treatment options to prolong survival; however, a new vaccine may change that.
Great strides have been made in cancer research this year, including targeted therapies that may soon be used as a standard of care.
Glioblastoma typically has low survival rates, but targeted therapies and surgery may offer hope for some patients.
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|